Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125922512 | 12592251 | 2 | F | 20160709 | 20160727 | 20160726 | 20160803 | EXP | IT-009507513-1607ITA009554 | MERCK | 43.00 | YR | M | Y | 0.00000 | 20160803 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125922512 | 12592251 | 1 | PS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | FREQUENCY: TOTAL | U | 20415 | TABLET | ||||||||
| 125922512 | 12592251 | 2 | SS | INVEGA | PALIPERIDONE | 1 | Oral | FREQUENCY: TOTAL | 0 | TABLET | |||||||||
| 125922512 | 12592251 | 3 | SS | RIVOTRIL | CLONAZEPAM | 1 | Oral | FREQUENCY: TOTAL | 0 | TABLET |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125922512 | 12592251 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125922512 | 12592251 | Intentional overdose | |
| 125922512 | 12592251 | Intentional self-injury | |
| 125922512 | 12592251 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125922512 | 12592251 | 1 | 20160709 | 20160709 | 0 | |
| 125922512 | 12592251 | 2 | 20160709 | 20160709 | 0 | |
| 125922512 | 12592251 | 3 | 20160709 | 20160709 | 0 |